Hsin‐Kuo Ko

494 total citations
28 papers, 296 citations indexed

About

Hsin‐Kuo Ko is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Hsin‐Kuo Ko has authored 28 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 2 papers in Surgery. Recurrent topics in Hsin‐Kuo Ko's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory Support and Mechanisms (12 papers) and Asthma and respiratory diseases (12 papers). Hsin‐Kuo Ko is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory Support and Mechanisms (12 papers) and Asthma and respiratory diseases (12 papers). Hsin‐Kuo Ko collaborates with scholars based in Taiwan, China and United States. Hsin‐Kuo Ko's co-authors include Diahn‐Warng Perng, Kang‐Cheng Su, Yi‐Han Hsiao, Hwa‐Yen Chiu, Yu‐Chin Lee, Yu Ru Kou, Kun‐Ta Chou, Tzong‐Shyuan Lee, Sheng‐Wei Pan and Chau‐Chyun Sheu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Life Sciences.

In The Last Decade

Hsin‐Kuo Ko

25 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsin‐Kuo Ko Taiwan 12 205 160 28 23 21 28 296
Mike Shields United Kingdom 6 159 0.8× 124 0.8× 54 1.9× 34 1.5× 22 1.0× 14 299
Rebeca Baz Spain 5 316 1.5× 140 0.9× 28 1.0× 12 0.5× 5 0.2× 8 369
И. В. Лещенко Russia 7 250 1.2× 152 0.9× 66 2.4× 28 1.2× 23 1.1× 60 330
Andrea Morris United States 7 364 1.8× 230 1.4× 31 1.1× 15 0.7× 3 0.1× 17 450
Joel Mermis United States 8 192 0.9× 139 0.9× 55 2.0× 41 1.8× 7 0.3× 18 322
Alberto De Felice Italy 9 347 1.7× 147 0.9× 37 1.3× 15 0.7× 6 0.3× 26 415
Dragoș Bumbăcea Romania 8 236 1.2× 248 1.6× 19 0.7× 34 1.5× 47 2.2× 22 351
Anders Andersson Sweden 11 114 0.6× 63 0.4× 22 0.8× 50 2.2× 13 0.6× 30 250
Francesca de Blasio Italy 8 154 0.8× 200 1.3× 8 0.3× 12 0.5× 16 0.8× 12 274
Suneela Zaigham Sweden 10 125 0.6× 57 0.4× 35 1.3× 8 0.3× 3 0.1× 28 221

Countries citing papers authored by Hsin‐Kuo Ko

Since Specialization
Citations

This map shows the geographic impact of Hsin‐Kuo Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐Kuo Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐Kuo Ko more than expected).

Fields of papers citing papers by Hsin‐Kuo Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin‐Kuo Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐Kuo Ko. The network helps show where Hsin‐Kuo Ko may publish in the future.

Co-authorship network of co-authors of Hsin‐Kuo Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin‐Kuo Ko. A scholar is included among the top collaborators of Hsin‐Kuo Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin‐Kuo Ko. Hsin‐Kuo Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Kang‐Cheng Su, Yi‐Han Hsiao, et al.. (2025). The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway Diseases. International Journal of COPD. Volume 20. 821–830.
4.
Hsiao, Yi‐Han, Kang‐Cheng Su, Jia‐Yih Feng, et al.. (2024). Correlations between blood vessel distribution, lung function and structural change in idiopathic pulmonary fibrosis. Respirology. 29(11). 962–968.
5.
Hsiao, Yi‐Han, et al.. (2023). Angiotensin-(1–7) attenuates SARS-CoV2 spike protein-induced interleukin-6 and interleukin-8 production in alveolar epithelial cells through activation of Mas receptor. Journal of Microbiology Immunology and Infection. 56(6). 1147–1157. 4 indexed citations
6.
Ko, Hsin‐Kuo, Yi‐Han Hsiao, Mei‐Jy Jeng, et al.. (2023). The role of transforming growth factor-β2 in cigarette smoke-induced lung inflammation and injury. Life Sciences. 320. 121539–121539. 5 indexed citations
7.
Hsiao, Yi‐Han, Chau‐Chyun Sheu, Hsin‐Yi Wang, et al.. (2022). Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study. International Journal of COPD. Volume 17. 2067–2078. 7 indexed citations
9.
Ko, Hsin‐Kuo, Shih-Lung Cheng, Ching‐Hsiung Lin, et al.. (2021). Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma. Scientific Reports. 11(1). 8425–8425. 22 indexed citations
10.
Su, Kang‐Cheng, Hsin‐Kuo Ko, Yi‐Han Hsiao, et al.. (2021). Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial. Archivos de Bronconeumología. 58(8). 601–610. 11 indexed citations
11.
Cheng, Shih-Lung, Ching‐Hsiung Lin, Kuo‐An Chu, et al.. (2021). Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations. Journal of the Formosan Medical Association. 120(10). 1821–1844. 15 indexed citations
12.
Chang, Yuh‐Lih, Hsin‐Kuo Ko, Chia‐Lin Chou, et al.. (2020). Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan. npj Primary Care Respiratory Medicine. 30(1). 7–7. 22 indexed citations
13.
Ko, Hsin‐Kuo, Kang‐Cheng Su, Jia‐Yih Feng, et al.. (2020). Functional parameters of small airways can guide bronchodilator use in idiopathic pulmonary fibrosis. Scientific Reports. 10(1). 18633–18633. 8 indexed citations
14.
Chiu, Hwa‐Yen, Yi‐Han Hsiao, Kang‐Cheng Su, et al.. (2019). Small Airway Dysfunction by Impulse Oscillometry in Symptomatic Patients with Preserved Pulmonary Function. The Journal of Allergy and Clinical Immunology In Practice. 8(1). 229–235.e3. 66 indexed citations
16.
Ko, Hsin‐Kuo, Yi‐Han Hsiao, Kang‐Cheng Su, et al.. (2019). Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients. Journal of the Chinese Medical Association. 82(6). 488–494. 3 indexed citations
17.
18.
Pan, Sheng‐Wei, et al.. (2017). Levels of exhaled carbon monoxide measured during an intervention program predict 1-year smoking cessation: a retrospective observational cohort study. npj Primary Care Respiratory Medicine. 27(1). 59–59. 11 indexed citations
19.
Chou, Kun‐Ta, Kang‐Cheng Su, Yi‐Han Hsiao, et al.. (2017). Post-bronchodilator Reversibility of FEV 1 and Eosinophilic Airway Inflammation in COPD. Archivos de Bronconeumología. 53(10). 547–553. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026